Evaluation of the toxicity of glucocorticoids in patients with autoimmune blistering disease using the Glucocorticoid Toxicity Index: A cohort studyCapsule Summary

Background: Glucocorticoids are the mainstay of treatment for autoimmune blistering diseases (AIBDs). The Glucocorticoid Toxicity Index (GTI) is a novel, outcome-based glucocorticoid-induced adverse effects monitoring instrument. Objective: To investigate whether the GTI score was able to accurately...

Full description

Bibliographic Details
Main Authors: Yicong Liang, MD, Faith A.P. Zeng, Tabrez Sheriff, MD, Anna Wilson, MD, Asli Bilgic, MD, Grant Feng, John H. Stone, MD, MPH, Dedee F. Murrell, MA, BMBCh, MD
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:JAAD International
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666328721000717